Preview

Discussion of Economics of Accounting from Contracting Perspective

Good Essays
Open Document
Open Document
522 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Discussion of Economics of Accounting from Contracting Perspective
A firm can be seen as a set of contracts, in which accounting information plays an important role of improving their efficiency. This memo discusses the contracting issues based on the team presentations in class, using Eli Lilly & Co. example. The two parts include the overview of Eli Lilly and the analysis of its sales contract.
OVERVIEW OF ELI LILLY
Goals & Objectives
Eli Lilly devotes its effort to invent and sell new drugs, with a mission of helping people live longer, healthier, more active lives. Eli Lilly’s business goal is keeping constant innovation of drugs. And its objective could be making profits by selling innovative drugs.
Business Processes
Under its business goal and objective, Eli Lilly’s business processes could be described as financing, investing in research and development, and selling. This circle of business processes ensures the normal function of the company.
Sources and use of Capital
In general, a company’s sources of capital are debt and equity. By looking at the recent financial statistics of Eli Lilly, Team 1 figured out that the main source of Eli Lilly’s capital is debt rather than equity. Additionally, the rate of total liabilities to total assets of Eli Lilly is much higher than that of the industry average. Thus we can tell that Eli Lilly obtains its capital mainly from its debtors.
On Eli Lilly’s recent balance sheet, it is not difficult to find that cash and cash equivalents together with short-term investment make a large portion of total assets. This could help guarantee the pay of debt and increase the liquidity of its assets.
ANALYSIS OF THE SALES CONTRACT
Objective of parties
In the sales contract, the two parties are Eli Lilly and its major customer. The objective of Eli Lilly is selling the drugs and makeing a profit, while the customer’s objective could be getting the products under desirable terms. For both of the parties, they will expect to maintain their cooperation to the future if the objectives

You May Also Find These Documents Helpful

  • Powerful Essays

    Society expects drug companies to improve people’s well-being and to behave like a nonprofit company not overly concerned with making large profits. However, investors expect pharmaceutical companies to earn profits making it unlikely that life-saving drugs will be sold at the lowest possible price. Some interest group is bound to be displeased with mutually exclusive expectations and the pharmaceutical industry is often criticized.…

    • 3675 Words
    • 15 Pages
    Powerful Essays
  • Better Essays

    In this case of Toy Central Cooperation the aim is to evaluate company risks and accounting issues facing a Toy Company, and establish how these issues would transform into required particular audit risks. In performing the analyses, there is need to draw on all-purpose information of toys and perhaps to investigate a number of of the accounting procedure issues confronting the Toy Company. Throughout this evaluation and analyses, there is a necessity for the Company to see a need for auditors to regard wide management issues concerning to supply chain management, as well as more advanced procedures relating to accounting and auditing in the Company.…

    • 1305 Words
    • 6 Pages
    Better Essays
  • Powerful Essays

    In the past several years some critical changes have been taking place in the pharmaceutical industry which included encouragement of generic prescriptions by the formularies, the exclusive listing of a single drug for a particular therapeutic prescription, enablement of bulk discount rate negotiation by health care insurers, and the minimization of the number of drugs to be put in the formularies. These changes pressured the pharmaceutical manufacturers to reduce the…

    • 1583 Words
    • 7 Pages
    Powerful Essays
  • Satisfactory Essays

    How Did Eli Lilly Start

    • 488 Words
    • 2 Pages

    Eli Lilly has pharmaceutical products that cover all types of medical needs. The main fields are oncology, cardiovascular, critical care, neuroscience, diabetes, men’s health and musculoskeletal.…

    • 488 Words
    • 2 Pages
    Satisfactory Essays
  • Powerful Essays

    has indicated its intent to reduce its stock in Eli Lilly and Co. by $2 Billion. The endowment is the largest shareholder in Eli Lilly. The sell off is intended to diversify the endowments assets and decrease the risk to its assets. This sell off adversely affects Eli Lilly's main anti-takeover provision. The endowment stake in Eli Lilly will decrease to 10.6% after the sell off.7…

    • 1158 Words
    • 5 Pages
    Powerful Essays
  • Good Essays

    Eli Lilly & Company

    • 688 Words
    • 3 Pages

    Using the financial ratios to analyze Eli Lilly’s competitive position, it is apparent that in most cases the company comes in second place with regards to its top 2 competitors. The short term solvency ratios indicate the liquidity of the company by comparing the current assets of the company with the current liabilities as a means to show how easily they can pay off their debts. Specifically Eli Lilly has a better current ratio than both companies, and a quick ratio that is better than Johnson and Johnson but only slightly worse than Pfizer.…

    • 688 Words
    • 3 Pages
    Good Essays
  • Good Essays

    And when it comes to asking the customer what they need. Eli Lilly asked the wrong customer. Instead of asking the people who are actually using diabetes care product, Eli Lilly went into doctor. What the doctor wants is totally opposite from what the patient need, the doctor want the customer come to them regularly because that’s the way that doctor earn money from. But patient or customers want to be able to control it by themselves. When Eli Lilly targeted wrong customer it eventually hurt its’ revenue.…

    • 817 Words
    • 4 Pages
    Good Essays
  • Powerful Essays

    Eli Lilly Case Analysis

    • 843 Words
    • 4 Pages

    Lilly BioVentures was created after Lilly employees saw the success of many of the Lilly equity investments in small biotech firms and recognized the need these start-ups had for “organizational memory, discipline, and deep commercial understanding resident in large, mature pharmaceutical companies.” This initiative was a great way for Lilly to stay relevant in the market with access to innovations that it might have otherwise discovered much later.…

    • 843 Words
    • 4 Pages
    Powerful Essays
  • Powerful Essays

    The biggest change in Abbott’s balance sheet can be seen in the composition of its asset accounts. In 2006, % of the firm’s assets were current, while 69% were of the long-term variety. In 2010, however, the portion of current assets increased by 7%. This increase in current assets is most visible in cash and short-term investments (4% in 2006 to 9% in 2010) and corresponds with a higher level of uncertainty in today’s economy. The fact that Abbott Laboratories has chosen to increase the value of liquid assets on its balance sheet indicates low returns on long-term investments and a preference of keeping cash on hand rather than reinvesting in the business.…

    • 1840 Words
    • 8 Pages
    Powerful Essays
  • Powerful Essays

    On January 10, 2006 the managing director of Merrill Lynch’s Equity- Linked Capital markets Group, Dar Maanavi, was reviewing the final drafts of a proposal for a convertible debt offering by MoGen, Inc. As a leading biotechnology company in the United States, MoGen had become an important client for Merrill Lynch over the years. In fact, if this deal were to be approved by MoGen at $5billion, it would represent Merrill Lynch’s third financing for MoGen in four years with proceeds raised totaling $10 billion. Moreover, this “convert” would be the largest such single offering in history. The proceeds were earmarked to fund a variety of capital expenditures, research and development expenses, working capital needs, as well as a share repurchase program.…

    • 3838 Words
    • 16 Pages
    Powerful Essays
  • Satisfactory Essays

    Eli Lily Case Study

    • 489 Words
    • 2 Pages

    It was a right strategy for Eli Lilly that started a joint venture with Ranbaxy to enter the Indian market. First of all, Ranbaxy was the second largest pharmaceutical company that manufactures bulk drugs and generic drugs in India, with a domestic market share of 15 per cent. It had established broad distribution network, and it was the second largest exporter of all products in India. Ranbaxy’s capital costs were 50 per cent to 75 per cent lower than those of comparable U.S. plants. Second, the timing was perfect for Eli Lilly to enter the Indian market. During 1970s, the Patents Act 1970 and the Drug Price Control Order (DPCO) was issued. And India was opening its drug market. Third, there was possibility to conduct cheap clinical trials in India.…

    • 489 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Course Outline

    • 591 Words
    • 3 Pages

    • Leo, K., Hoggett, J., and Sweeting, J. (2012) Company Accounting, 9th edition, John Wiley & Sons, Milton: Old, ISBN: 9781742466378.…

    • 591 Words
    • 3 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Our main motive is to supply customers with drugs and medications equally safe and equally reliable at economical prices thus helping to save their money and time. Thousands of satisfied customers across the globe have put their trust in us and most keep asking for repeat orders. We always believe in Customers’ satisfaction thus ensure in providing quality services all over the world.…

    • 284 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    Like every other manufacturing companies, pharmaceutical companies aim to manufacture products that must be sold for a profit in order for the company to survive and grow. The difference lies in the product they sell affecting their consumers’ health and life directly. This makes the business risky. Without a new discover of a ‘blockbuster’ drug every few years, the drug company survival is at risk. For instance, only one out of every ten thousand discovered compounds actually becomes an approved drug for sale. Much expense is incurred in the early phases of development of compounds that will not become approved drugs. In addition, it takes about 7 to 10 years and an average cost of 500 million dollars to develop each new drug. This money is spent before the FDA approves the drug, and if the drug is not approved, the company loses the money. These expenses must be covered by the revenue from compounds that successfully become approved drugs. Moreover, only 3 out of every 20 approved drugs bring in sufficient revenue to cover their developmental costs, and only 1 out of every 3 approved drugs generates enough money to cover the development costs of previous failures.…

    • 529 Words
    • 3 Pages
    Good Essays
  • Good Essays

    The two companies in this IJV were both significant players within their home countries, Eli Lilly and Company in the US and Ranbaxy Laboratories Limited from India. When the possibility of establishing a joint venture was approached in 1992, the Indian market for pharmaceuticals was becoming more open to foreign direct investment. Also India at the time was putting a limit on the amount of foreign ownership, from 40 percent to 51 percent, creating less foreign competition in the region. With numerous of opportunities opening up within the Indian market, Eli Lilly saw this as a stepping-stone for future clinical testing. Both companies having common backgrounds and goals of being a research oriented international pharmaceutical company, embarking on a joint venture seemed ideal.…

    • 1614 Words
    • 7 Pages
    Good Essays

Related Topics